Pathology Analysis & Statistics, May 2014 (p20)

Talk to Louis

+1 718 618 4302

Search inside this page

Publishers

All regions

You might be interested in: cancer, breast cancer, prostate cancer, more »

571-620 of about 5 600 reports

Purchase Reports From Reputable Market Research Publishers

Exact Sciences Corporation (EXAS) - Product Pipeline Analysis, 2014 Update

Exact Sciences Corporation (EXAS) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • May 2014
  • by Global Data

Summary Exact Sciences Corporation (Exact) is a molecular diagnostics company. It focuses on the early detection and prevention of colorectal cancer. The company's proprietary non-invasive stool-based ...

  • Industries : Pathology
  • Countries : United States
Sanofi (SAN) - Product Pipeline Analysis, 2014 Update

Sanofi (SAN) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • May 2014
  • by Global Data

Summary Sanofi is a diversified global healthcare company. It undertakes the discovery, development and marketing of therapeutic solutions. The company offers a broad range of prescription medicines, and ...

  • Industries : Pathology
  • Countries : United States, France, South Korea
Merit Medical Systems, Inc. (MMSI) - Product Pipeline Analysis, 2014 Update

Merit Medical Systems, Inc. (MMSI) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • May 2014
  • by Global Data

Summary Merit Medical Systems, Inc. (Merit Medical) is a medical device company. It undertakes the manufacturing and marketing of single-use medical devices for use in interventional and diagnostic procedures. ...

  • Industries : Pathology
  • Countries : United States
Physician Views: An assessment of GlaxoSmith-Kline's Breo launch - Can Anoro do any better?

Physician Views: An assessment of GlaxoSmith-Kline's Breo launch - Can Anoro do any better?

  • $ 731
  • Industry report
  • May 2014
  • by Firstword Pharma

Set against the backdrop of a streamlined therapeutic focus, GlaxoSmithKline faced a challenging Q1 in the US respiratory segment despite its market-leading position in the asthma and chronic obstructive ...

  • Industries : Pathology
  • Countries : United States
Physician Views: What drives physician brand loyalty in the ultra-competitive multiple sclerosis market?

Physician Views: What drives physician brand loyalty in the ultra-competitive multiple sclerosis market?

  • $ 731
  • Industry report
  • May 2014
  • by Firstword Pharma

The multiple sclerosis market is arguably one of the most competitive in pharma, shaped in part by a handful of products (Avonex, Betaseron, Copaxone and Rebif) that are both effective, very well established ...

  • Industries : Pathology
  • Countries : United States
Physician Views: How do neurologists value multiple sclerosis medical affairs teams - what could they be doing better?

Physician Views: How do neurologists value multiple sclerosis medical affairs teams - what could they be doing better?

  • $ 645
  • Industry report
  • June 2014
  • by Firstword Pharma

Medical affairs teams are playing an increasingly critical role for pharmaceutical manufacturers. They are in a prime position to navigate the industry's continued transition from merely selling drugs ...

  • Industries : Pathology
  • Countries : United States
Physician Views: Five key diabetes market questions ahead of ADA 2014

Physician Views: Five key diabetes market questions ahead of ADA 2014

  • $ 645
  • Industry report
  • June 2014
  • by Firstword Pharma

This year's annual meeting of the American Diabetes Association (ADA) - which will take place June 13-17 in San Francisco - intersects the diabetes market at a notable point of evolution. In the long-acting ...

  • Industries : Pathology
  • Countries : United States
Physician Views: Can new biologic therapies expand the severe asthma market?

Physician Views: Can new biologic therapies expand the severe asthma market?

  • $ 645
  • Industry report
  • June 2014
  • by Firstword Pharma

Description Looking to build on the success of Roche and Genentech's Xolair franchise, a clutch of biologic therapies being developed for the treatment of severe asthma are expected to move from the clinic ...

  • Industries : Pathology
  • Countries : United States
Physician Views: Five key pre-ASCO questions on the immuno-oncology race

Physician Views: Five key pre-ASCO questions on the immuno-oncology race

  • $ 645
  • Industry report
  • May 2014
  • by Firstword Pharma

Description Scope The annual meeting of the American Society of Clinical Oncology (ASCO) will take place between May 30 and June 3, and for the second year in succession, conference headlines will be dominated ...

  • Industries : Pathology
  • Countries : United States
Brinzolamide  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Brinzolamide - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • July 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Duloxetine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Duloxetine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • July 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Sildenafil  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Sildenafil - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • July 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Sitagliptin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Sitagliptin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • July 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Temsirolimus  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Temsirolimus - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • July 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Donepezil  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Donepezil - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • July 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Irbesartan  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Irbesartan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • July 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Rivastigmine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Rivastigmine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • July 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Ropinirole  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Ropinirole - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • July 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Valsartan  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Valsartan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • July 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Dasatinib  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Dasatinib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • July 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Erlotinib  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Erlotinib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • July 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Gefitinib  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Gefitinib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • July 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Lapatinib  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Lapatinib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • July 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Rivaroxaban  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Rivaroxaban - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • July 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Pazopanib  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Pazopanib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • July 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Flomoxef  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Flomoxef - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • July 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe
Vilazodone  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Vilazodone - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • July 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Canagliflozin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Canagliflozin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • July 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Vandetanib  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Vandetanib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • July 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Pharma-Patient Engagement: insights from patient opinion leaders

Pharma-Patient Engagement: insights from patient opinion leaders

  • $ 495
  • Industry report
  • June 2014
  • by Firstword Pharma

Description TPatients and Pharma want the same thing, but for different reasons. Patients want access, support and information about the latest drugs while Pharma needs market access for sales and profits ...

  • Industries : Pathology
  • Countries : Europe, United Kingdom, World
About 38 000 reports

Download Unlimited Documents from Trusted Public Sources

Bmj - Company Report, July 2014

  • July 2014
    2 pages
  • Vaccine  

    Infectious Dise...  

  • India  

    Asia  

View report >

About 200 Companies

Read our Company Profiles

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

GlaxoSmithKline P.L.C.

United States

Eli Lilly and Co.

United States

Pfizer Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.